BWXT to Restart Existing TRISO Nuclear Fuel Production Line and Expand Capacity
Company to hireup to 60 new workers to attain increased production targets (LYNCHBURG, Va. – Oct. 2, 2019) – BWX Technologies, Inc. (NYSE: BWXT) announced today that it is in the process of restarting its existing TRISO nuclear fuel production line and is planning to expand its existing capacity within approximately 12 months. The expansion […]
BWXT Medical and Bayer AG Enter into Agreement for the Development and Production of Actinium-225
(OTTAWA, Ontario – September 16, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Medical Ltd. subsidiary (BWXT Medical) has entered into an agreement with Bayer AG (Bayer) to develop Actinium-225 (Ac-225) supply and further partnering opportunities on finished products as both companies broaden their respective commercialization strategies for targeted radionuclide therapies […]
BWXT Awarded CA$40 Million Contract to Supply Heat Exchangers for Bruce Power
(CAMBRIDGE, ON – August 19, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced a contract from Bruce Power valued at approximately CA$40 million to supply four moderator heat exchangers. The contract, which will be executed by subsidiary BWXT Canada Ltd. at its Cambridge, Ontario facility, involves engineering and fabrication of these specialized components. Moderator […]
BWX Technologies Reports Second Quarter 2021 Results and Continues Progress On Future Growth Milestones
Lynchburg, VA – August 2, 2021 – BWX Technologies, Inc. (NYSE: BWXT) (“BWXT”, “we”, “us” or the “Company”) reported second quarter 2021 revenue of $505 million, about even compared with $505 million in the second quarter 2020. Net income for the second quarter 2021 was $59.3 million, or $0.62 per diluted share, compared with GAAP net […]
BWXT Medical Enters into a New Long-Term Agreement with Boston Scientific
(Ottawa, Ontario – May 10, 2021) – BWXT Medical Ltd. (BWXT Medical) announced today that it has entered into a new long-term, mutually exclusive agreement to manufacture TheraSphere™ Y-90 Glass Microspheres for Boston Scientific, a leading global medical device company. Developed for the treatment of patients with hepatocellular carcinoma (HCC), TheraSphere treatment is comprised of millions […]
BWX Technologies Reports First Quarter 2021 Results and Commences New Multi-Year Guidance Framework
Highlights: BWX Technologies, Inc. (NYSE: BWXT) (“BWXT”, “we”, “us” or the “Company”) reported first quarter 2021 revenue of $528 million, a 2.6% decrease compared with $542 million in the first quarter 2020. Net income for the first quarter 2021 was $69.7 million, or $0.73 per diluted share, compared with GAAP net income of $75.5 million, […]
BWXT Expands Technical Fellows Program
Diverse Team of Employees Selectedfor Scientific and Engineering Contributions (LYNCHBURG, Va. – April 27, 2021) – BWX Technologies, Inc. (NYSE: BWXT) has expanded its existing technical fellows initiative by selecting 25 additional employees for the program in recognition of their scientific and engineering accomplishments at the company. Individuals selected as fellows are recognized as senior […]
BWXT Announces $2.2 Billion in Contracts for Naval Nuclear Reactor Components and Fuel
(LYNCHBURG, Va. – April 20, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today the award of U.S. Naval Nuclear Propulsion Program contracts totaling approximately $2.2 billion, including future-year options, for the manufacture of naval nuclear reactor components and fuel. “Today’s announcement marks a continuation of a more-than 65-year-old trusted relationship with the U.S. government […]
BWXT Awarded $690 Million Extension for Environmental Management Work at Portsmouth
(LYNCHBURG, Va. – April 6, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced a contract extension, valued at up to $690 million including options, from the U.S. Department of Energy (DOE) for environmental management work at Portsmouth Gaseous Diffusion Plant. The agreement took effect on March 29, 2021, and includes a one-year extension with […]
BWXT Awarded Additional Nuclear Thermal Propulsion Work for NASA
(LYNCHBURG, Va. – April 1, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that it is continuing its groundbreaking Nuclear Thermal Propulsion (NTP) design, manufacturing development, and test support work for NASA. NTP is one of the technologies that is capable of propelling a spacecraft to Mars, and this contract continues BWXT’s work that […]